Related Experiment Videos

Identification of CD7 glycoprotein as an accessory molecule in HIV-1-mediated syncytium formation and cellfree

A I Sato1, F B Balamuth, K E Ugen

  • 1Department of Pathology, University of Pennsylvania, Philadelphia 19104.

Insights

The human T cell surface molecule CD7 plays a crucial role in Human Immunodeficiency Virus (HIV) infection. Blocking CD7 significantly inhibits HIV-induced cell fusion and viral spread, highlighting its importance in the infection process.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Human Immunodeficiency Virus (HIV) infection of CD4+ T cells involves cell-to-cell fusion, leading to syncytium formation.
  • Membrane fusion is a critical step for both cell-free virion infection and syncytium development.

Purpose of the Study:

  • To investigate the role of the human T cell surface molecule CD7 in the HIV-1 fusion process.
  • To determine if CD7 is a target for inhibiting HIV-1 infection and cell fusion.

Main Methods:

  • Utilized anti-CD7 monoclonal antibodies (mAbs) to block HIV-1-induced cell-cell fusion and cell-free infection in SupT1 cells.
  • Performed epitope mapping to identify regions on CD7 involved in membrane fusion inhibition.
  • Assessed infectability of CD7-deficient cells by cell-free virus and their susceptibility to fusion inhibition.

Main Results:

  • Anti-CD7 mAbs effectively inhibited HIV-1-induced cell-cell fusion and prevented cell-free infection.
  • The inhibitory effect of anti-CD7 antibodies was not due to cross-reactivity with CD4 or viral proteins.
  • Cells lacking CD7 expression (CD7-) showed reduced susceptibility to cell-free viral infection and were more easily inhibited from fusing.

Conclusions:

  • Human CD7 is a key molecule involved in the HIV-1 fusion process.
  • Targeting CD7 presents a potential strategy for inhibiting HIV-1 infection and preventing syncytium formation.

Related Concept Videos